Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Non-cash Items (2016 - 2022)

vTv Therapeutics (VTVT) has disclosed Non-cash Items for 8 consecutive years, with $1.9 million as the latest value for Q1 2022.

  • Quarterly Non-cash Items fell 42.42% to $1.9 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2022, down 42.42% year-over-year, with the annual reading at $3.3 million for FY2021, 8.33% down from the prior year.
  • Non-cash Items hit $1.9 million in Q1 2022 for vTv Therapeutics, down from $3.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $3.6 million in Q4 2020 to a low of $500000.0 in Q2 2021.
  • Historically, Non-cash Items has averaged $2.0 million across 5 years, with a median of $1.9 million in 2022.
  • Biggest YoY gain for Non-cash Items was 863.16% in 2018; the steepest drop was 69.77% in 2018.
  • Year by year, Non-cash Items stood at $1.3 million in 2018, then decreased by 1.51% to $1.3 million in 2019, then surged by 181.16% to $3.6 million in 2020, then fell by 8.33% to $3.3 million in 2021, then plummeted by 42.42% to $1.9 million in 2022.
  • Business Quant data shows Non-cash Items for VTVT at $1.9 million in Q1 2022, $3.3 million in Q4 2021, and $2.6 million in Q3 2021.